John Wiley & Sons (FRA:2F7) 1-Year Sharpe Ratio: 0.27 (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2F7 John Wiley & Sons Inc FRA:2F7
55 GF Score
Price €45.60
GF Value €32.61
! 7 Warning Signs
View Full Analysis

What is John Wiley & Sons 1-Year Sharpe Ratio?

John Wiley & Sons FRA:2F7 +1.79% 55 1-Year Sharpe Ratio is 0.27 as of Aug. 05, 2026. GuruFocus rates FRA:2F7 with a GF Score™ of 55/100 and a GF Value™ of €32.61. The stock has 7 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-05), John Wiley & Sons's 1-Year Sharpe Ratio is 0.27.


John Wiley & Sons  (FRA:2F7) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


John Wiley & Sons 1-Year Sharpe Ratio Related Terms


FRA:2F7 vs TDAY, SCHL, LEE: 1-Year Sharpe Ratio Comparison

For the Publishing subindustry, John Wiley & Sons's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


John Wiley & Sons 1-Year Sharpe Ratio vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, John Wiley & Sons's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where John Wiley & Sons's 1-Year Sharpe Ratio falls into.


FRA:2F7
55GF Score
John Wiley & Sons Inc FRA:2F7
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

John Wiley & Sons 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.27 mean?
John Wiley & Sons (FRA:2F7) has a 1-Year Sharpe Ratio of 0.27 as of Aug. 05, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for John Wiley & Sons and its competitors.
Is John Wiley & Sons' 1-Year Sharpe Ratio too high?
John Wiley & Sons' current 1-Year Sharpe Ratio is 0.27. Overall, John Wiley & Sons has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does John Wiley & Sons' 1-Year Sharpe Ratio compare to TDAY and SCHL?
John Wiley & Sons' 1-Year Sharpe Ratio of 0.27 can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Media - Diversified company?
A good 1-Year Sharpe Ratio depends on the Media - Diversified industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for John Wiley & Sons and its competitors. John Wiley & Sons's current 1-Year Sharpe Ratio is 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is John Wiley & Sons stock overvalued right now?
John Wiley & Sons (FRA:2F7) has a current 1-Year Sharpe Ratio of 0.27. The stock's GF Value™ is €32.61, compared to a current price of €45.60 — trading 39.8% above its estimated fair value. The current 1-Year Sharpe Ratio is 0.27. John Wiley & Sons' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For John Wiley & Sons (FRA:2F7), the current 1-Year Sharpe Ratio is 0.27 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is John Wiley & Sons (FRA:2F7) Overvalued in 2026?

Based on GuruFocus' analysis, John Wiley & Sons stock appears to be overvalued. The current stock price of €45.60 is trading 39.8% above its estimated GF Value™ of €32.61.

Key valuation signals for FRA:2F7:

  • 1-Year Sharpe Ratio: 0.27
  • GF Value™: €32.61 vs. price of €45.60 (39.8% above fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the FRA:2F7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


John Wiley & Sons Business Description

Address 111 River Street, Hoboken, NJ, USA, 07030
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
55GF Score

Get the complete analysis for FRA:2F7

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€45.60
Price
€32.61
GF Value